MENU
NEWS WORTHY
NEWS WORTHY

Press Releases

April 1, 2020
Locana Expands Leadership Team With Appointment of Micah Mackison, as Chief Business Officer
SAN DIEGO, Apr. 1, 2020 – Locana, Inc., a leading RNA-targeting gene therapy company, today announced the appointment of Micah Mackison, as Chief Business Officer. Bringing more than 20 years of...
READ MORE
December 10, 2019
Locana Expands Leadership Team With Appointment of former Casebia CEO, James Burns, Ph.D., as Chief Executive Officer
SAN DIEGO, Dec. 10, 2019 – Locana, Inc., a leading RNA-targeting gene therapy company, today announced the appointment of James Burns, Ph.D., as chief executive officer, as a key step in expanding...
READ MORE
MORE

EVENTS & PRESENTATIONS

MAY 27, 2020
Locana Participates in the 25th Annual Meeting of the RNA Society to Share Research Regarding RNA-targeting Gene Therapy for Human Genetic Diseases.
READ MORE

MAY 13, 2020
Locana Presents Poster at ASGCT 2020: AAV9 Mediated Delivery of RNA Targeting CRISPR Corrects Molecular and Functional Phenotypes in Myotonic Dystrophy Type 1 Mouse Model
READ MORE

News Coverage

August 3 2020, CELL & GENE
The RNA-Targeting Era in Genetic Medicine
READ MORE

July 22 2020, Biospace
Locanabio’s Combo RNA Modification Platform Targets Multiple RNA Dysfunctions with One Injection
READ MORE

July/August 2020, DDNews
Q&A: Branching out with RNA-targeting Cas systems
READ MORE

July 11, 2020
Locanabio has been presented an excellence in RNA research RNA SOCIETY Poster Award at RNA 2020 On-line – the 25th Annual Meeting of the RNA SOCIETY
READ MORE

September 23, 2019
Biocom Announces Fourth Annual Catalyst Award Winners
READ MORE